SPONSOR
Fujian Shengdi Pharmaceutical Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 3, Phase 2
Conditions studied: Overweight or ObesitySubjects With Moderate-to-severe OSA and Obesity Who Are on PAP TherapyMild to Moderate HypertensionT2DM
Fujian Shengdi Pharmaceutical Co., Ltd. is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Overweight or Obesity, Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy, Mild to Moderate Hypertension, T2DM.
The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fujian Shengdi Pharmaceutical Co., Ltd.
How many clinical trials has Fujian Shengdi Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Fujian Shengdi Pharmaceutical Co., Ltd., of which 4 are actively recruiting participants. These trials cover conditions including Overweight or Obesity, Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy, Mild to Moderate Hypertension. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fujian Shengdi Pharmaceutical Co., Ltd. research focus on?
Fujian Shengdi Pharmaceutical Co., Ltd. clinical trials span Overweight or Obesity, Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy, Mild to Moderate Hypertension, T2DM. The research pipeline includes Phase 1, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fujian Shengdi Pharmaceutical Co., Ltd. clinical trial?
To participate in a Fujian Shengdi Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fujian Shengdi Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Fujian Shengdi Pharmaceutical Co., Ltd.
NCT07150962 Phase 1
Recruiting
Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
Overweight or Obesity
NCT06994650 Phase 3
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
NCT07297797 Phase 2
Recruiting
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
Mild to Moderate Hypertension
NCT07599410 Phase 2
Recruiting
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
T2DM
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology